No headlines found.
Bone Biologics Expands Trial Sites
Globe Newswire (Tue, 8-Sep 8:30 AM ET)
Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Globe Newswire (Thu, 3-Sep 8:30 AM ET)
Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1
Globe Newswire (Wed, 12-Aug 8:00 AM ET)
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
Globe Newswire (Thu, 23-Jul 8:00 AM ET)
Globe Newswire (Tue, 7-Jul 8:00 PM ET)
Bone Biologics - Warrants trades on the stock market under the symbol BBLGW.
As of October 2, 2026, BBLGW stock price climbed to $5.53 with 5,504 million shares trading.
BBLGW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, BBLGW traded as high as $200.64 and as low as $.70.
BBLGW has underperformed the market in the last year with a return of -46.8%, while the SPY ETF gained +16.1%. In the last 3 month period, BBLGW fell short of the market, returning -63.1%, while SPY returned +3.6%. However, in the most recent 2 weeks BBLGW has outperformed the stock market by returning +36.2%, while SPY returned +1.0%.
BBLGW support price is $2.81 and resistance is $5.79 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BBLGW shares will trade within this expected range on the day.
